Skip to content

Endoscopic Mucosal Resection For People with Colonic Polyps.

The Safety and Efficacy of Endoscopic Mucosal Resection for Large Polyps at Middlemore Hospital

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12619001404112
Acronym
MEMORY study
Enrollment
250
Registered
2019-10-14
Start date
2019-11-01
Completion date
2020-11-01
Last updated
2019-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Endoscopic mucosal resection (EMR) has become the primary therapy in the management of large polyps in the colon. It is now the standard of care for safe and effective resection of large (greater than 20mm) non-pedunculated polyps. We aim to perform a comprehensive review of our EMR practice, in particular to determine the safety, efficacy and outcomes, including polyp recurrence at our institution for polyps greater than 20mm undergoing EMR.

Interventions

To perform a comprehensive review of our Endoscopic Submucosal Resection (EMR) practice, in particular to determine the safety, efficacy and outcomes, including polyp recurrence at our institution for polyps greater than 20mm undergoing EMR. The primary outcome will be establishing the proportion of patients who have bleeding and/or perforation. In addition, we wish to define risk factors for both complication and failed/unsuccessful EMR (defined as initial incomplete removal OR recurrence at

To perform a comprehensive review of our Endoscopic Submucosal Resection (EMR) practice, in particular to determine the safety, efficacy and outcomes, including polyp recurrence at our institution for polyps greater than 20mm undergoing EMR. The primary outcome will be establishing the proportion of patients who have bleeding and/or perforation. In addition, we wish to define risk factors for both complication and failed/unsuccessful EMR (defined as initial incomplete removal OR recurrence at scheduled surveillance follow-up). Participants will not be required to perform any additional tasks in this study. The total duration of observation for the study will be 1 year post the date of the procedure. All patients in this study will receive usual standard of care practice with EMR - there will be no alteration in practice or data collected.

Sponsors

Middlemore Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Consecutive patients undergoing an EMR of a non-pedunculated lesion >20mm.

Exclusion criteria

Incomplete data only

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026